Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment.
Abraham André Arturo Geng-CahuaymeBlanca Peregrín-PastorMónica Ramos-AlbiacEnar Recalde-VizcayJuan Sebastián Parada-ZuluagaJordi Giralt-López de SagredoXavier Maldonado-PijoanAlexandra Giraldo-MarínPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Lung SABR in patients with poor pulmonary function may be effective with acceptable toxicity.